Panicked Healthcare Lobbyists Descend On Massachusetts To Save The 60th Democratic Vote For Reform: "We've been following the special election in Massachusetts, where the GOP hopes to pull a surprise upset in the race to fill Ted Kennedy's seat.
If they do pull it off, healthcare reform is instantly in trouble, as the Democrats drop below 60.
But money is coming to the rescue of Democrat Martha Coakley -- healthcare industry lobbyist money, specifically.
Tim Carney identifies several of her top fundraisers. Take a look at who they represent:
* Thomas Boggs, Patton Boggs: Bristol-Myers Squibb
* Chuck Brain, Capitol Hill Strategies: Amgen, BIO, Merck, PhRMA
* Susan Brophy, Glover Park Group: Blue Cross, Pfizer
* Steven Champlin, Duberstein Group: AHIP, Novartis, Sanofi-Aventis
* Licy Do Canto, Raben Group: Amgen
* Gerald Cassidy, Cassidy & Associates: U. Mass Memorial Health Care
* David Castagnetti, Mehlman, Vogel, Castagnetti: Abbot Labs, AHIP, Astra-Zenaca, General Electric, Humana, Merck, PhRMA.
* Steven Elmendorf, Elmendorf Strategies: Medicines Company, PhRMA, United Health
* Shannon Finley, Capitol Counsel: Amgen, Astra-Zeneca, Blue Cross, GE, PhRMA, Sanofi-Aventis.
* Heather Podesta, Heather Podesta & Partners: Cigna, Eli Lilly, HealthSouth
* Tony Podesta, Podesta Group: Amgen, GE, Merck, Novartis.
* Robert Raben, Raben Group: Amgen, GE."
No comments:
Post a Comment
Spamming will be removed.
Due to spamming. Comments need to be moderated. Your post will appear after moderated regardless of your views as long as they are not abusive in nature. Consistent abusive posters will not be viewed but deleted.
Note: Only a member of this blog may post a comment.